SCHEMBL7877573

SCHEMBL7877573

CCN(CC)Cc1cccc(COc2cc(C(F)(F)F)c3cc(C(=O)N=C(N)NC)[nH]c3c2)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GYS1 P13807 1/20 0.36
MRGPRX4 Q96LA9 4/20 0.35
BCHE P06276 2/20 0.35
CFD P00746 1/20 0.35
MAOB P27338 3/20 0.34
AR P10275 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
HRH3 Q9Y5N1 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HTT P42858 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7882185 0.93 HRH3 (0.41) BCHEMAOBARL3MBTL1HRH3
SCHEMBL7881398 0.92 MAOB (0.36) MRGPRX4CFDMAOBARL3MBTL1
SCHEMBL7877875 0.89 RHEB (0.34) BCHEAR
SCHEMBL7879920 0.89 MAOB (0.37) MRGPRX4CFDMAOBARL3MBTL1
SCHEMBL7884603 0.88 MAOB (0.36) GYS1MRGPRX4BCHECFDMAOB
SCHEMBL7881849 0.88 MAOB (0.36) BCHEMAOBARLMNA
Hydrochloric Acid SCHEMBL7881834 0.86 IDO1 (0.40) MAOBARKDM4EALDH1A1
SCHEMBL7879952 0.85 RHEB (0.35) ARHRH3
SCHEMBL7882351 0.85 CFD (0.44) GYS1BCHECFDMAOBL3MBTL1
SCHEMBL7877982 0.84 MAOB (0.37) MAOBAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed